LONDON (AP) — AstraZeneca board rejects sweetened takeover offer from Pfizer. Recommended Stories Arizona GOP leader seeks hearing on taxpayer risk in Paramount merger case Paramount seeks $1.88 billion bond to cover financial losses from blocked merger Midwest senators open investigation into Roblox allegedly putting profits over child safety